Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

被引：2
作者：
Park, Se Yoon
Baek, Yae Jee [2 ]
Kim, Jung Ho [3 ]
Seong, Hye [4 ]
Kim, Bongyoung [1 ,5 ]
Kim, Yong Chan [3 ,6 ]
Yoon, Jin Gu [4 ]
Heo, Namwoo [6 ]
Moon, Song Mi [7 ]
Kim, Young Ah [8 ]
Song, Joon Young [4 ]
Choi, Jun Yong [3 ]
Park, Yoon Soo [3 ,6 ]
机构：
[1] Hanyang Univ, Dept Internal Med, Div Infect Dis, Seoul Hosp, Seoul, South Korea
[2] Soonchunhyang Univ, Soonchunhyang Univ Coll Med, Dept Internal Med, Seoul Hosp, Seoul, South Korea
[3] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[4] Korea Univ, Korea Univ Coll Med, Dept Internal Med, Div Infect Dis,Guro Hosp, Seoul, South Korea
[5] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[6] Yonsei Univ, Dept Infect Dis, Yongin Severance Hosp, Yongin, South Korea
[7] Seoul Natl Univ, Seoul Natl Univ Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[8] Natl Hlth Insurance Serv Ilsan Hosp, Dept Lab Med, Goyang, South Korea
来源：
INFECTION AND CHEMOTHERAPY | 2024年 / 56卷 / 03期
关键词：
Carbapenem-resistant Enterobacterales; Antibacterial agents; Practice guideline; BLOOD-STREAM INFECTIONS; URINARY-TRACT-INFECTIONS; COMPLICATED INTRAABDOMINAL INFECTION; CRITICALLY-ILL PATIENTS; GRAM-NEGATIVE BACTERIA; KLEBSIELLA-PNEUMONIAE; CEFTAZIDIME-AVIBACTAM; PSEUDOMONAS-AERUGINOSA; INTRAVENOUS COLISTIN; DISEASES SOCIETY;
D O I：
10.3947/ic.2024.0038
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management of common CRE infections and diagnostics, whereas each specific section is structured with key questions that are focused on antibacterial agents and disease-specific approaches. This guideline covers both currently available and upcoming antibacterial agents in Korea.
引用
收藏
页码：308 / 328
页数：21
相关论文
共 151 条
[1]   Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City [J].
Abdallah, Marie ;
Olafisoye, Olawole ;
Cortes, Christopher ;
Urban, Carl ;
Landman, David ;
Quale, John .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) :1802-1805
[2]   Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections [J].
Ackley, Renee ;
Roshdy, Danya ;
Meredith, Jacqueline ;
Minor, Sarah ;
Anderson, William E. ;
Capraro, Gerald A. ;
Polk, Christopher .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
[3]   A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections [J].
Agyeman, Akosua A. ;
Bergen, Phillip J. ;
Rao, Gauri G. ;
Nation, Roger L. ;
Landersdorfer, Cornelia B. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (01)
[4]   Early Experience With Eravacycline for Complicated Infections [J].
Alosaimy, Sara ;
Molina, Kyle C. ;
Claeys, Kimberly C. ;
Andrade, Justin ;
Truong, James ;
King, Madeline A. ;
Pullinger, Benjamin M. ;
Huang, Glen ;
Morrisette, Taylor ;
Lagnf, Abdalhamid M. ;
Davis, Susan L. ;
Rybak, Michael J. .
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05)
[5]   Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae [J].
Alraddadi, Basem M. ;
Saeedi, Mohammed ;
Qutub, Mohammed ;
Alshukairi, Abeer ;
Hassanien, Ashraf ;
Wali, Ghassan .
BMC INFECTIOUS DISEASES, 2019, 19 (01)
[6]  
[Anonymous], 2010, Guidelines for the Prevention and Clinical Management of Snakebite in Africa
[7]   Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial [J].
Bassetti, Matteo ;
Echols, Roger ;
Matsunaga, Yuko ;
Ariyasu, Mari ;
Doi, Yohei ;
Ferrer, Ricard ;
Lodise, Thomas P. ;
Naas, Thierry ;
Niki, Yoshihito ;
Paterson, David L. ;
Portsmouth, Simon ;
Torre-Cisneros, Julian ;
Toyoizumi, Kiichiro ;
Wunderink, Richard G. ;
Nagata, Tsutae D. .
LANCET INFECTIOUS DISEASES, 2021, 21 (02) :226-240
[8]   Antimicrobial resistance and treatment: an unmet clinical safety need [J].
Bassetti, Matteo ;
Russo, Alessandro ;
Carnelutti, Alessia ;
La Rosa, Alessandro ;
Righi, Elda .
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) :669-680
[9]   Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases [J].
Benchetrit, Laura ;
Mathy, Vincent ;
Armand-Lefevre, Laurence ;
Bouadma, Lila ;
Timsit, Jean-Francois .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (01)
[10]   Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline [J].
Boyd, Sara E. ;
Livermore, David M. ;
Hooper, David C. ;
Hope, William W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (10)
12345678910